Results for tag: "Gastrointestinal Cancer Drug"

The Gastrointestinal Cancer Drug market is a subset of the larger Oncology Drugs market. It includes drugs used to treat cancers of the digestive system, such as colorectal, pancreatic, and gastric cancers. These drugs are used to reduce the size of tumors, reduce symptoms, and improve quality of life. Common treatments include chemotherapy, targeted therapy, and immunotherapy. The Gastrointestinal Cancer Drug market is highly competitive, with many companies developing and marketing drugs to treat these cancers. Some of the major players in the market include Bristol-Myers Squibb, Merck, Roche, AstraZeneca, and Eli Lilly. Other companies, such as Novartis, Pfizer, and Amgen, are also active in the market. Show Less Read more